Navigation Links
ReSearch Pharmaceutical Services anuncia a Marc Wolff como responsable financiero
Date:7/25/2013

FORT WASHINGTON, Pennsylvania, 25 de julio de 2013 /PRNewswire/ -- ReSearch Pharmaceutical Services, Inc. (RPS), una CRO de próxima generación que proporciona soluciones de desarrollo clínico global en fase 1-4 para las industrias de dispositivos médicos y biofarmacéutica, anunció hoy que Marc Wolff se une a la organización en el cargo de responsable financiero.

En su cargo, Marc dirigirá todas las finanzas, impuestos y aspectos de tesorería de los negocios, incluyendo las prácticas de contabilidad, presupuesto, planificación financiera, finanzas, interfaz con la comunidad financiera, análisis financiero, adquisiciones y empresas y control del rendimiento financiero, de impuestos y tesorería. Se une a la compañía procedente de Catalent Pharma Solutions, donde trabajó en un doble cargo como responsable de finanzas mundial de Softgel Technologies además de ser vicepresidente y responsable general de Softgel Businesses en Australia y Japón.

Wolff cuenta con más de 15 años de experiencia como responsable financiero en corporaciones públicas y privadas, disponiendo entre 50 millones de dólares y 1.500 millones de dólares en ingresos, con un record establecido de éxito en las principales organizaciones globales de finanzas y un valor empresariales creciente destacado. 

Acerca de RPS
ReSearch Pharmaceutical Services (RPS), el principal proveedor mundial de mercado de innovadoras soluciones de desarrollo clínico de externalización, ofrece soluciones de desarrollo clínico de fase I-IV globales completas para las industrias farmacéutica, biotecnológica, de dispositivos médicos y diagnóstico, personalizadas por tipo (grandes, tamaño medio y pequeño). Construida de forma orgánica, RPS es la organización de investigación clínica (CRO) de crecimiento más rápido dentro de las 10 primeras, y cuenta con más de 5.000 empleados y realiza operaciones en más de 64 países, disponiendo de estructuras internas propias. Estas estructuras han proporcionado a RPS y sus socios una flexibilidad de desarrollo y crecimiento superior.

Si desea más información sobre RPS, visite www.rpsweb.com.


'/>"/>
SOURCE ReSearch Pharmaceutical Services, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Water Treatment Industry Reports: Equipment Research for US & Global Wastewater Treatment Markets
2. Organovo and Methuselah Foundation Announce Funding of Bioprinting Research at Research Institutions
3. Exosome Diagnostics and QIAGEN Partner to Launch Comprehensive Line of Biofluid Nucleic Acid Kits to Address Limitations of Tissue Biopsy in Clinical Research Market
4. BioDelivery Sciences Announces the Hiring of Adrian Hepner, M.D. as Vice President of Clinical Research & Regulatory Affairs
5. Pain Management Devices Market (Electrical Stimulators, Radiofrequency Ablation, Analgesic Pumps, Neurostimulation Devices) Is Expected to Reach USD 5.0 Billion Globally in 2018: Transparency Market Research
6. ResearchMoz.us: Biotechnology Market By Application (Biopharmacy, Bioservices, Bioagri, Bioindustrial), By Technology (Fermentation, Tissue Regeneration, PCR, Nanobiotechnology, DNA Sequencing & Others) - Global Industry Analysis, Size, Share, Growt
7. ResearchDx, the leading Contract Diagnostics Organization, completes their expansion into a new facility
8. Heptares Achieves First Research Milestone in Research Collaboration with Cubist
9. Leadership Through Research Collaboration Is Reflected In Articles Published In Alzheimers Association Journal
10. Todays Research: Delcath Systems, Astex Pharma, BioMarin Pharma, and Akorn
11. Froedtert & The Medical College of Wisconsin Clinical Cancer Center Joins Elekta and Philips Research Consortium on MRI-Guided Radiation Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... , March 27, 2017 ... specialty clinical-stage pharmaceutical company specializing in the development of ... public offering in the United States ... each ADS representing 40 ordinary shares of the ... In addition, Therapix has granted the underwriters a ...
(Date:3/27/2017)...  Cryoport, Inc. (NASDAQ: CYRX, CYRXW) ("Cryoport" or the ... of common stock in an underwritten public offering under ... Securities and Exchange Commission (the "SEC"). The offering is ... be no assurance as to whether or when the ... size or terms of the offering. Cryoport also expects ...
(Date:3/27/2017)... 2017 To mark the end of Save Your ... leader in digital imaging solutions, will showcase Canon eye care ... New York,s Jacob Javits Center from ... sponsored by the American Optometric Association, is observed annually in ... comprehensive eye exams. In recognition of this observance, Canon ...
Breaking Medicine Technology:
(Date:3/28/2017)... ... March 28, 2017 , ... City trips have soared 82% ... Trends Report). As travelers visit both urban destinations, they are faced with exploration ... exposure. In response, the outdoor industry has blurred the lines between fashion and ...
(Date:3/28/2017)... ... 2017 , ... Z-Medica, LLC, a leading developer and marketer ... will acquire QuikClot® Bleeding Control Kits® (BCK) to equip up to 1,000 schools ... by the American College of Surgeons, U.S. Department of Defense, Department of Homeland ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... Paul Yost, will begin serving as new board chair for Orange County health ... will serve the remainder of soon-to-be former chair Mark Refowitz’s term, which runs ...
(Date:3/28/2017)... (PRWEB) , ... March 28, 2017 , ... ... health plans work, the Self-Funding Success website has recently developed and published an ... Health Plans ” was created based on common inquiries the site’s team of ...
(Date:3/28/2017)... ... March 28, 2017 , ... Prominant bariatric surgeon and ... thrilled to offer the recently FDA-approved Obalon Balloon System to his patients. The ... Advanced Surgical’s already comprehensive list of weight-loss services. Dr. Liu is proud ...
Breaking Medicine News(10 mins):